Thyroid hormone receptor agonists
US12391677B2 · kind B2 · utility
0Cited by
1References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 11, 2019 |
| Grant date | Aug 19, 2025 |
| Priority date | — |
| Expiry date | Mar 11, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/650905
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are novel thyroid hormone receptor (TR) agonists e.g., having Formula I, II, or III. Also provided are methods of preparing the novel TR agonists and method of using the novel TR agonists for treating diseases or disorder modulated by TR agonists, such as NAFLD, NASH, diabetes, hyperlipidemia and/or hypercholesterolemia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.